Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will publish all evidence provided by immunologists to inform the decision not to procure Evusheld.

The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency initiative, RAPID C-19 and a national expert policy working group. These groups considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies and concluded there is currently insufficient evidence of benefit to recommend deployment. The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and agree that this should now be referred to the National Institute for Health and Care Excellence for further evaluation.

The Department intends to publish further details of the clinical advice received shortly.